Locally Advanced Solid Tumors

Oncology·MeSH: Neoplasm Metastasis

5 drugs in development·4 companies·2 clinical trials

Drug Pipeline by Phase

Phase 2(2)

Drug	Company
rtx-224	Rubius Therapeutics, Inc. (RUBY)
rtx-240	Rubius Therapeutics, Inc. (RUBY)

Phase 1(1)

Drug	Company
amg 436	AMGEN INC (AMGN)

Phase 1/Phase 2(2)

Drug	Company
oral repotrectinib	Turning Point Therapeutics, Inc. (TPTX)
oral repotrectinib	TG THERAPEUTICS, INC. (TGTX)

BioSniper tracks 5 drugs in development for Locally Advanced Solid Tumors across 4 companies.

There are 2 clinical trials targeting Locally Advanced Solid Tumors tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.